Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anemia, Aplastic | 2 | 2019 | 230 | 0.790 |
Why?
|
Lymphoma, Primary Cutaneous Anaplastic Large Cell | 1 | 2018 | 8 | 0.650 |
Why?
|
Kaposi Varicelliform Eruption | 1 | 2018 | 47 | 0.620 |
Why?
|
Hepatitis E | 1 | 2017 | 76 | 0.520 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2019 | 617 | 0.500 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2017 | 147 | 0.500 |
Why?
|
Hematologic Diseases | 2 | 2010 | 496 | 0.460 |
Why?
|
Mycosis Fungoides | 2 | 2012 | 170 | 0.410 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2019 | 1374 | 0.390 |
Why?
|
Thrombocytopenia | 3 | 2006 | 1181 | 0.380 |
Why?
|
Skin Neoplasms | 8 | 2021 | 5821 | 0.370 |
Why?
|
Hematologic Agents | 1 | 2010 | 40 | 0.340 |
Why?
|
Biological Products | 1 | 2018 | 914 | 0.330 |
Why?
|
Glioblastoma | 1 | 2019 | 3482 | 0.230 |
Why?
|
Medical Oncology | 2 | 2022 | 2321 | 0.210 |
Why?
|
Adenovirus E1A Proteins | 2 | 2000 | 73 | 0.200 |
Why?
|
Kanamycin Kinase | 2 | 1998 | 34 | 0.190 |
Why?
|
Myasthenia Gravis | 1 | 2024 | 214 | 0.190 |
Why?
|
Neoplasms, Adnexal and Skin Appendage | 1 | 2021 | 27 | 0.180 |
Why?
|
Heparin | 2 | 2006 | 1634 | 0.180 |
Why?
|
Myositis | 1 | 2024 | 271 | 0.180 |
Why?
|
Lymphomatoid Papulosis | 1 | 2000 | 16 | 0.180 |
Why?
|
Blood Coagulation Disorders | 1 | 2003 | 350 | 0.180 |
Why?
|
Melanoma | 1 | 2018 | 5709 | 0.170 |
Why?
|
Hematology | 1 | 2023 | 243 | 0.170 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2000 | 375 | 0.170 |
Why?
|
Critical Illness | 2 | 2003 | 2723 | 0.160 |
Why?
|
Fatal Outcome | 3 | 2019 | 1834 | 0.150 |
Why?
|
Disabled Persons | 4 | 2008 | 1225 | 0.150 |
Why?
|
Quality of Health Care | 1 | 2013 | 4330 | 0.150 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9031 | 0.150 |
Why?
|
Gene Rearrangement | 2 | 2000 | 1125 | 0.140 |
Why?
|
Blood Transfusion | 1 | 2003 | 1298 | 0.140 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2021 | 732 | 0.130 |
Why?
|
Pentosyltransferases | 1 | 1996 | 62 | 0.130 |
Why?
|
Career Choice | 1 | 2022 | 756 | 0.130 |
Why?
|
Electronic Health Records | 1 | 2013 | 4811 | 0.130 |
Why?
|
DNA Helicases | 1 | 2000 | 851 | 0.120 |
Why?
|
Adenoviridae | 1 | 1998 | 1084 | 0.120 |
Why?
|
Lichen Planus | 1 | 2015 | 70 | 0.120 |
Why?
|
Incidental Findings | 1 | 2019 | 697 | 0.120 |
Why?
|
Anemia | 1 | 2003 | 1509 | 0.110 |
Why?
|
Medicare | 6 | 2008 | 6770 | 0.110 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 1117 | 0.110 |
Why?
|
Mycophenolic Acid | 1 | 1996 | 348 | 0.110 |
Why?
|
Herpesvirus 1, Human | 1 | 2018 | 753 | 0.110 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2915 | 0.110 |
Why?
|
Oncolytic Virotherapy | 1 | 2018 | 516 | 0.110 |
Why?
|
Gene Deletion | 1 | 2000 | 2665 | 0.100 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4026 | 0.100 |
Why?
|
Critical Care | 1 | 2003 | 2696 | 0.090 |
Why?
|
Phosphotransferases | 1 | 1992 | 303 | 0.090 |
Why?
|
Oncology Service, Hospital | 1 | 1991 | 57 | 0.090 |
Why?
|
Lymphoma, T-Cell | 2 | 2004 | 304 | 0.090 |
Why?
|
Anticoagulants | 1 | 2006 | 4812 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2000 | 1405 | 0.090 |
Why?
|
3T3 Cells | 3 | 1998 | 1085 | 0.090 |
Why?
|
Social Security | 2 | 2007 | 101 | 0.090 |
Why?
|
Mastectomy | 2 | 2008 | 1822 | 0.080 |
Why?
|
Neoplasms | 4 | 2010 | 22170 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2825 | 0.070 |
Why?
|
Clinical Competence | 1 | 2023 | 4792 | 0.070 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58976 | 0.070 |
Why?
|
Gentamicins | 2 | 1998 | 243 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9280 | 0.070 |
Why?
|
Humans | 29 | 2024 | 761504 | 0.070 |
Why?
|
Acute Disease | 1 | 2017 | 7237 | 0.070 |
Why?
|
Oncogenes | 1 | 1992 | 1222 | 0.070 |
Why?
|
Medical Informatics | 1 | 2013 | 733 | 0.060 |
Why?
|
SEER Program | 5 | 2008 | 1450 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2020 | 4234 | 0.060 |
Why?
|
Male | 14 | 2024 | 360804 | 0.060 |
Why?
|
Complement Inactivating Agents | 1 | 2024 | 53 | 0.060 |
Why?
|
Transfection | 3 | 1998 | 5774 | 0.060 |
Why?
|
Restriction Mapping | 2 | 1996 | 851 | 0.050 |
Why?
|
Patient Admission | 1 | 1991 | 1367 | 0.050 |
Why?
|
Methyltransferases | 1 | 2006 | 377 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2759 | 0.050 |
Why?
|
Prednisone | 2 | 2024 | 1563 | 0.050 |
Why?
|
Cell Division | 3 | 2000 | 4465 | 0.050 |
Why?
|
Reed-Sternberg Cells | 1 | 2001 | 72 | 0.050 |
Why?
|
Erythropoietin | 1 | 2006 | 719 | 0.050 |
Why?
|
Mastectomy, Segmental | 1 | 2006 | 955 | 0.050 |
Why?
|
Hemostasis | 1 | 2003 | 467 | 0.050 |
Why?
|
Pityriasis Lichenoides | 1 | 2000 | 6 | 0.050 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 2373 | 0.050 |
Why?
|
HELLP Syndrome | 1 | 2000 | 40 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 1991 | 1998 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8529 | 0.040 |
Why?
|
Accreditation | 1 | 2023 | 473 | 0.040 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2000 | 106 | 0.040 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2000 | 186 | 0.040 |
Why?
|
North America | 1 | 2023 | 1276 | 0.040 |
Why?
|
Lymph Node Excision | 2 | 2021 | 1271 | 0.040 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2000 | 130 | 0.040 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2000 | 168 | 0.040 |
Why?
|
Mohs Surgery | 1 | 2021 | 222 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2008 | 5315 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 1992 | 7594 | 0.040 |
Why?
|
Genetic Complementation Test | 1 | 1998 | 554 | 0.040 |
Why?
|
Methotrexate | 1 | 2004 | 1719 | 0.040 |
Why?
|
Platelet Transfusion | 1 | 2000 | 297 | 0.040 |
Why?
|
Attitude to Death | 1 | 2000 | 400 | 0.040 |
Why?
|
Clone Cells | 2 | 2001 | 1659 | 0.030 |
Why?
|
Cell Size | 1 | 1998 | 624 | 0.030 |
Why?
|
Hygromycin B | 1 | 1996 | 11 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 2000 | 422 | 0.030 |
Why?
|
Puromycin | 1 | 1996 | 42 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2748 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2015 | 12974 | 0.030 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1996 | 189 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1992 | 8547 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2000 | 1870 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2000 | 4174 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4591 | 0.030 |
Why?
|
Survival Rate | 3 | 2021 | 12725 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2000 | 974 | 0.030 |
Why?
|
Lung Neoplasms | 4 | 2008 | 13380 | 0.030 |
Why?
|
Remission Induction | 1 | 2000 | 2396 | 0.030 |
Why?
|
Colonic Neoplasms | 2 | 2000 | 2538 | 0.030 |
Why?
|
Sequence Deletion | 1 | 1998 | 1494 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5428 | 0.030 |
Why?
|
Hodgkin Disease | 1 | 2001 | 1378 | 0.030 |
Why?
|
RNA Splicing | 1 | 1998 | 918 | 0.030 |
Why?
|
Breast Neoplasms | 4 | 2008 | 21012 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 11742 | 0.030 |
Why?
|
POEMS Syndrome | 1 | 1992 | 12 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2004 | 4352 | 0.030 |
Why?
|
Base Sequence | 2 | 2001 | 12441 | 0.030 |
Why?
|
Cell Line | 2 | 2000 | 15601 | 0.030 |
Why?
|
Neoplasm Staging | 4 | 2008 | 11121 | 0.030 |
Why?
|
Survival Analysis | 2 | 2008 | 10090 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 1998 | 1756 | 0.030 |
Why?
|
Brain | 1 | 2019 | 27112 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2008 | 3358 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2008 | 1784 | 0.020 |
Why?
|
Aged | 8 | 2021 | 169289 | 0.020 |
Why?
|
Telangiectasis | 1 | 1991 | 78 | 0.020 |
Why?
|
Lymphoma | 1 | 2000 | 1901 | 0.020 |
Why?
|
Health Services Research | 2 | 2007 | 1812 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1992 | 777 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2001 | 17635 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2004 | 1116 | 0.020 |
Why?
|
Pre-Eclampsia | 1 | 2000 | 1231 | 0.020 |
Why?
|
Catastrophic Illness | 1 | 1991 | 62 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6484 | 0.020 |
Why?
|
Female | 12 | 2021 | 392644 | 0.020 |
Why?
|
Adult | 7 | 2017 | 221177 | 0.020 |
Why?
|
Mice | 4 | 2000 | 81525 | 0.020 |
Why?
|
Drug Resistance | 1 | 1996 | 1596 | 0.020 |
Why?
|
Retrospective Studies | 6 | 2021 | 80636 | 0.020 |
Why?
|
Fees and Charges | 1 | 1991 | 192 | 0.020 |
Why?
|
Primary Myelofibrosis | 1 | 1991 | 209 | 0.020 |
Why?
|
Recurrence | 2 | 2000 | 8465 | 0.020 |
Why?
|
Mastocytosis | 1 | 1991 | 150 | 0.020 |
Why?
|
Diagnosis-Related Groups | 1 | 1991 | 449 | 0.020 |
Why?
|
Middle Aged | 9 | 2024 | 220895 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2000 | 13446 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 1998 | 7407 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2000 | 1896 | 0.020 |
Why?
|
Terminal Care | 1 | 2000 | 1760 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15842 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2000 | 2298 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 1992 | 1519 | 0.020 |
Why?
|
Decision Making | 1 | 2000 | 3929 | 0.020 |
Why?
|
United States | 6 | 2008 | 72334 | 0.020 |
Why?
|
Gene Expression | 1 | 1998 | 7581 | 0.020 |
Why?
|
Genotype | 1 | 2000 | 12990 | 0.020 |
Why?
|
Marital Status | 1 | 2007 | 426 | 0.020 |
Why?
|
Health Maintenance Organizations | 1 | 2008 | 659 | 0.020 |
Why?
|
Animals | 4 | 2000 | 168459 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5336 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2000 | 4320 | 0.010 |
Why?
|
Health Resources | 1 | 1991 | 935 | 0.010 |
Why?
|
Risk Assessment | 2 | 2021 | 23995 | 0.010 |
Why?
|
Escherichia coli | 1 | 1996 | 4217 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1998 | 12795 | 0.010 |
Why?
|
Fee-for-Service Plans | 1 | 2008 | 700 | 0.010 |
Why?
|
Risk Factors | 1 | 2010 | 74206 | 0.010 |
Why?
|
Gastritis | 1 | 2004 | 199 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2000 | 11903 | 0.010 |
Why?
|
Phenotype | 1 | 2000 | 16591 | 0.010 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2001 | 40 | 0.010 |
Why?
|
Vincristine | 1 | 2004 | 1036 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2001 | 329 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2008 | 1119 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2008 | 1835 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2001 | 1058 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2008 | 3514 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2004 | 2218 | 0.010 |
Why?
|
Pregnancy | 1 | 2000 | 29874 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 2004 | 831 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2001 | 11076 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54425 | 0.010 |
Why?
|
Cause of Death | 1 | 2006 | 3683 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1246 | 0.010 |
Why?
|
Disease Progression | 2 | 2004 | 13506 | 0.010 |
Why?
|
Palliative Care | 1 | 1991 | 3598 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12059 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2008 | 7827 | 0.010 |
Why?
|
Mutation | 1 | 1998 | 30052 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10508 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12463 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6132 | 0.010 |
Why?
|
NF-kappa B | 1 | 2000 | 2490 | 0.010 |
Why?
|
Registries | 1 | 2008 | 8224 | 0.010 |
Why?
|
Crohn Disease | 1 | 2004 | 2279 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1992 | 11460 | 0.010 |
Why?
|
Heart Diseases | 1 | 2004 | 2781 | 0.010 |
Why?
|
Age Factors | 1 | 2008 | 18395 | 0.010 |
Why?
|
Data Collection | 1 | 2000 | 3322 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2000 | 2421 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2001 | 3466 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2000 | 4915 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 59243 | 0.000 |
Why?
|
Emotions | 1 | 2000 | 2739 | 0.000 |
Why?
|
Skin | 1 | 2001 | 4484 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2008 | 39106 | 0.000 |
Why?
|
Cohort Studies | 1 | 2006 | 41487 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2008 | 64680 | 0.000 |
Why?
|
Hospitalization | 1 | 2000 | 10723 | 0.000 |
Why?
|
Prognosis | 1 | 2000 | 29625 | 0.000 |
Why?
|
Quality of Life | 1 | 2000 | 13367 | 0.000 |
Why?
|
Signal Transduction | 1 | 2000 | 23445 | 0.000 |
Why?
|